摘要
Journal of Wound CareVol. 30, No. 11 Guest EditorialThe future of bioengineering personalised skin on demand for large skin defectsDaniela Marino, Vincent RonfardDaniela MarinoCEO and co-founder of CUTISS AG, SwitzerlandSearch for more papers by this author, Vincent RonfardChief Innovation Officer, CUTISS AG, SwitzerlandSearch for more papers by this authorDaniela Marino; Vincent RonfardPublished Online:7 Nov 2021https://doi.org/10.12968/jowc.2021.30.11.878AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References 1 Ronfard V, Vertès AA, May MH et al. Evaluating the past, present, and future of regenerative medicine: a global view. Tissue Eng Part B Rev 2017; 23(2):199–210. https://doi.org/10.1089/ten.teb.2016.0291 Crossref, Medline, Google Scholar2 Chua AWC, Khoo YC, Tan BK et al. Skin tissue engineering advances in severe burns: review and therapeutic applications. Burns Trauma 2016; 4:3. https://doi.org/10.1186/s41038-016-0027-y Crossref, Medline, Google Scholar3 Doulgkeroglou M-N, Di Nubila A, Niessing B et al. Automation, monitoring, and standardization of cell product manufacturing. Front Bioeng Biotechnol 2020; 8:811. https://doi.org/10.3389/fbioe.2020.00811 Crossref, Medline, Google Scholar4 Lipsitz YY, Millligan WD, Fitzpatrick I et al. (2017) A roadmap for cost-of-goods planning to guide economic production of cell therapy products. Cytotherapy 2017; 19(12):1383–1391. https://doi.org/10.1016/j.jcyt.2017.06.009 Crossref, Medline, Google Scholar5 Weng T, Zhang W, Xia Y et al. 3D bioprinting for skin tissue engineering: Current status and perspectives. J Tissue Engineering 2021; 12: 1–28. https://doi.org/10.1177/20417314211028574 Crossref, Google Scholar6 Varkey M, Visscher DO, van Zuijlen PPM et al. Skin bioprinting: the future of burn wound reconstruction? Burns Trauma 2019; 7:4. https://doi.org/10.1186/s41038-019-0142-7 Crossref, Medline, Google Scholar7 Meuli M, Hartmann-Fritsch F, Hüging M et al. A cultured autologous dermo-epidermal skin substitute for full-thickness skin defects: a phase i, open, prospective clinical trial in children. Plast Reconstr Surg 2019; 144(1):188–198. https://doi.org/10.1097/prs.0000000000005746 Crossref, Medline, Google Scholar FiguresReferencesRelatedDetails 2 November 2021Volume 30Issue 11ISSN (print): 0969-0700ISSN (online): 2052-2916 Metrics History Published online 7 November 2021 Published in print 2 November 2021 Information© MA Healthcare LimitedPDF download